Screen for anthelmintics, using larvae of Ascaris suum

Area of Science:

• Veterinary Parasitology
• Pharmacology
• Drug Discovery

Background:

• Ascaris suum is a significant parasitic nematode affecting livestock and human health.
• Effective anthelmintic drugs are crucial for controlling parasitic infections.
• Understanding drug mechanisms and developing new screening methods is essential.

Purpose of the Study:

• To evaluate the efficacy of 12 known anthelmintic compounds against Ascaris suum larval development in vitro.
• To assess the utility of an in vitro multiwell culture system as a bioassay for anthelmintic activity.
• To investigate the correlation between in vitro drug effects and known in vivo anthelmintic activity.

Main Methods:

• A multiwell culture system was employed to monitor Ascaris suum larval development (L2 to L3 and L3 to L4 stages).
• Larval survival, development, and motility were assessed in the presence of 12 different anthelmintic compounds at various concentrations.
• The influence of serum presence on drug activity was also investigated.

Main Results:

• Several anthelmintics, including albendazole (ABZ), mebendazole, and thiabendazole, inhibited L2 to L3 larval development at low concentrations (0.01 microgram/ml).
• Albendazole and mebendazole were effective in blocking L3 to L4 development at 0.01 microgram/ml, while other drugs showed varying efficacy and required higher concentrations.
• Drug activity could be reduced by the presence of serum, and in vitro results did not consistently correlate with established in vivo efficacy.

Conclusions:

• In vitro development of Ascaris suum larvae provides a convenient and sensitive bioassay for screening anthelmintic activity.
• This in vitro system could potentially be used to screen for anthelmintic residues in edible tissues.
• Further research is needed to fully correlate in vitro findings with in vivo drug performance.